CIBC Private Wealth Group LLC increased its position in HCA Healthcare Inc (NYSE:HCA) by 0.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 156,246 shares of the company’s stock after acquiring an additional 449 shares during the period. CIBC Private Wealth Group LLC’s holdings in HCA Healthcare were worth $19,445,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in HCA Healthcare by 0.3% during the third quarter. Vanguard Group Inc. now owns 19,916,360 shares of the company’s stock worth $2,770,765,000 after buying an additional 66,808 shares during the period. Vanguard Group Inc grew its stake in HCA Healthcare by 0.3% during the third quarter. Vanguard Group Inc now owns 19,916,360 shares of the company’s stock worth $2,770,765,000 after buying an additional 66,808 shares during the period. FMR LLC grew its stake in HCA Healthcare by 98.7% during the third quarter. FMR LLC now owns 10,907,407 shares of the company’s stock worth $1,517,438,000 after buying an additional 5,419,134 shares during the period. LSV Asset Management grew its stake in HCA Healthcare by 0.3% during the third quarter. LSV Asset Management now owns 5,474,392 shares of the company’s stock worth $761,597,000 after buying an additional 15,004 shares during the period. Finally, Lyrical Asset Management LP grew its stake in HCA Healthcare by 2.0% during the third quarter. Lyrical Asset Management LP now owns 4,078,212 shares of the company’s stock worth $567,361,000 after buying an additional 80,081 shares during the period. 72.85% of the stock is owned by institutional investors and hedge funds.
In other HCA Healthcare news, SVP Deborah M. Reiner sold 466 shares of the stock in a transaction on Tuesday, February 5th. The shares were sold at an average price of $139.07, for a total transaction of $64,806.62. Following the transaction, the senior vice president now directly owns 5,037 shares in the company, valued at approximately $700,495.59. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP J William Morrow sold 263 shares of the stock in a transaction on Thursday, February 7th. The shares were sold at an average price of $140.60, for a total transaction of $36,977.80. Following the transaction, the senior vice president now owns 5,922 shares in the company, valued at $832,633.20. The disclosure for this sale can be found here. Insiders have sold a total of 29,336 shares of company stock worth $4,077,257 over the last quarter. 2.80% of the stock is currently owned by insiders.
HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 29th. The company reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.59 by $0.40. The business had revenue of $12.27 billion during the quarter, compared to the consensus estimate of $12.10 billion. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.12 earnings per share. As a group, analysts anticipate that HCA Healthcare Inc will post 10.02 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 1st will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.14%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.35. The ex-dividend date is Thursday, February 28th. HCA Healthcare’s dividend payout ratio is 14.33%.
Several equities research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, November 20th. Argus boosted their price objective on shares of HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Tuesday, November 6th. Oppenheimer boosted their price objective on shares of HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. Stephens assumed coverage on shares of HCA Healthcare in a research note on Monday, January 14th. They set an “overweight” rating and a $143.00 price objective for the company. Finally, UBS Group assumed coverage on shares of HCA Healthcare in a research note on Thursday, November 15th. They set a “buy” rating and a $162.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating and eighteen have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $148.43.
TRADEMARK VIOLATION WARNING: This piece was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.com-unik.info/2019/02/13/cibc-private-wealth-group-llc-has-19-45-million-stake-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Index Funds
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.